Drug Type Chemical drugs |
Synonyms- |
Target |
Mechanism ATP1A3 modulators(Sodium/potassium-transporting ATPase subunit alpha-3 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Alternating Hemiplegia of Childhood | Preclinical | US | 17 Sep 2024 | |
Alternating Hemiplegia of Childhood | Preclinical | US | Unravel Biosciences, Inc.Startup | 17 Sep 2024 |